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Skin and ocular inﬂammation can co-exist. We
report a case of non-diabetic necrobiosis lipoidica
with uveitis and retinal vasculitis.
Case report
Skin and ocular inﬂammation can co-exist in
several inﬂammatory conditions such as rheuma-
toid arthritis, sarcoidosis, Wegener’s granulomato-
sis and polyarteritis nodosa.
1 We report a case of
non-diabetic necrobiosis lipoidica in whom
periods of skin inﬂammation were associated
with exacerbations of ocular inﬂammation in the
form of intermediate uveitis and retinal vasculitis
over 20 years.
In July 1988, a 43-year-old Caucasian woman
presented with blurred vision and ﬂoaters with a
three-year history of recurrent iritis in both eyes.
Visual acuities were 6/5 in the right eye and 6/6
in the left eye. As she had bilateral inﬂammatory
cells in the anterior chamber and a vitreitis with
inferior vitreous aggregates (‘snowballs’) in both
eyes, she was diagnosed with bilateral intermedi-
ate uveitis, which over a 9-month period led to
cytoid macular oedema in the right eye (visual
acuity 6/6). Over the next 24 moths bilateral oblit-
erative peripheral retinal vasculitis occurred,
though visual acuity remained 6/9 and 6/6i n
right and left eye. Inﬂammatory markers, infective
screen, serum ACE and chest X-ray were all within
normal limits. Concurrently she had developed
atrophic plaques on the skin of both shins associ-
ated with impaired light-touch sensation on the
right leg. Her past medical history was signiﬁcant
for granuloma annulare on her hands at age 24
years. Fasting blood glucose and HbA1C were
normal and Doppler ultrasound studies of the
lower limbs excluded arteriovenous pathology. A
skin biopsy conﬁrmed the diagnosis of necrobiosis
lipoidica.
The skin plaques intermittently ulcerated in the
years following diagnosis, coinciding with exacer-
b a t i o n so fh e ro c u l a rs i g n so ne a c ho c c a s i o n .
Cutaneous treatments over a 20-year period ranged
from intralesional triamcinolone (10 mg/mL) to
oral nicotinamide 500 mg tds, clofazime 200 mg
od, cyclophosphamide 100 mg bd (3 mgkg
–1)a n d
topical GM-CSF, each variably effective.
Her ocular inﬂammation required only topical
corticosteroids, until 10 years after ﬁrst presen-
tation when the retinal vasculitis in the left eye
(Figure 1a) led to peripheral retinal neovasculari-
sation, treated successfully with laser panretinal
photocoagulation. Visual acuities were 6/9 in the
right eye and 6/6 in the left eye. Both ocular and
cutaneous inﬂammation remained controlled for
another 9 years, when she had another concurrent
recurrence of both bilateral intermediate uveitis
and necrobiosis lipoidica (Figure 1b).
Repeat skin biopsy (Figure 1c) revealed normal
epidermis but the dermis showed a moderate,
sharply demarcated predominantly plasmacytic
perivascular inﬁltrate with foci of multinucleated
giant cells in the deep dermis. The deeper part
of the sample showed necrobiotic collagen. There
was a small focus of fat necrosis within the col-
lagen and the medium-size deep dermal artery
showed moderately thickened media. Mild posi-
tive staining for complement C3 was seen in the
endothelium of the small dermal vessels on
immunohistochemical staining but no obvious
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1IgM deposits were present. There were no features
of active vasculitis (i.e. intramural neutrophils,
ﬁbrin cufﬁng, red cell leakage or leucocytoclasis).
The overall histological appearances were in
keeping with the clinical diagnosis of necrobiosis
lipoidica.
Discussion
Several skin disorders can be associated with
ocular inﬂammation, involving the sclera or pro-
ducing intraocular inﬂammation.
1 Rheumatoid
arthritis is a common systemic autoimmune
disease that presents with inﬂammatory signs in
the joints, and can also manifest skin abnormal-
ities in the form of rheumatoid nodules, small
painless vasculitic infarcts around the nails and
pulp of the ﬁngers and pyoderma gangrenosum,
with ulcerative lesions developing especially in
traumatised areas. The ocular manifestations of
this condition include scleritis, keratitis and dry
eyes. Sarcoidosis is a granulomatous disease of
unknown aetiology, which affects the skin in up
to 35% of patients with manifestations such as
erythema nodosum and lupus pernio. In terms
of ocular involvement sarcoid can be associated
with uveitis, both anterior and posterior, which
typically manifests itself as retinal vasculitis.
Wegener’s granulomatosis is an uncommon multi-
system disease characterized by vasculitis and
necrotizing, granulomatous inﬂammation. Up to
50% of the patients will show skin lesions, with
palpable purpura or petechial lesions that can pro-
gress with ulcerations being the most common.
Other forms of skin involvement involve vesicles,
pustules, ecchymoses, splinter haemorrhages of
ﬁngernails and even gangrene of digits. Ocular
manifestations include orbital inﬂammation, and
scleritis as the most common, and also peripheral
ulcerative keratitis, uveitis and papillitis. Necrotiz-
ing scleritis is a common and destructive form of
ocular inﬂammation. In polyarteritis nodosa, a
systemic vasculitis involving small and medium-
sized blood vessels, the classic skin ﬁnding is
that of nodules tracing the course of superﬁcial
arteries. The most common lesions are non-
speciﬁc macules, papules and urticaria. The
ocular manifestations, depending upon the site
of vascular involvement include retinal vasculitis,
papillitis and involvement of orbital vessels.
Thepathogenesisofnecrobiosislipoidicaremains
uncertain although theories include an immune
complex vasculitis, a collagen production disorder
and a manifestation of diabetic microangiopathy.
2
The association of necrobiosis lipoidica with dia-
b e t e sm e l l i t u si sc o n t r o v e r s i a lh o w e v e r .I no n e
large series, two-thirds of patients with necrobiosis
Figure 1
a. Fluorescein angiogram of the periphery of the left eye shows leakage of dye from inﬂamed retinal veins
and peripheral shutdown of the retinal vasculature; b. Necrobiosis plaques on both shins; c. Histology
from bunch biopsy of necrobiotic skin. Note plasmacytic perivascular inﬁltrate with multinucleated giant
cells in the deep dermis (haematoxylin & eosin, x20)
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2lipoidicahaddiabetes.
3Inanothersmallerretrospec-
tive study, a much lower incidence of diabetes (11%)
was found in patients with necrobiosis lipoidica at
the time of presentation.
4
Clinically, well-demarcated atrophic yellowish
plaques are characteristic, typicallyon the pre-tibial
skin. The plaques often have a shiny surface and
telangiectasia. Although the condition is usually
asymptomatic, hypoaesthesia and hypohidrosis
may be found within plaques. Lesions are
commonly bilateral, tend to persist and may ulce-
rate. Squamous cell carcinoma developing in long-
standing lesions has been reported.
5
The co-existence of ocular inﬂammation and
necrobiosis lipoidica has received sparse attention
in the literature. To our knowledge this possible
association has been reported only in the context
of a diabetic patient with sarcoidosis, who devel-
oped chronic unilateral iridocyclitis and necrobio-
sis.
6 Our patient differs from that report in the fact
that she developed both skin and ocular inﬂam-
mation without diabetes.
We would therefore recommend that patients
presenting to general physicians and dermatolo-
gists with necrobiosis lipoidica should be asked
about ocular symptoms and referred to an
ophthalmologist for evaluation as appropriate.
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